Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
作者信息
Inoue Ken-Ichiro, Takano Hirohisa, Yanagisawa Rie, Yoshikawa Toshikazu
出版信息
Chest. 2003 Jul;124(1):413-4; author reply 414.
PMID:12853558
Abstract
摘要
相似文献
1
Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
Chest. 2003 Jul;124(1):413-4; author reply 414.
2
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis.
Eur Respir J. 2004 Oct;24(4):708. doi: 10.1183/09031936.04.00076904.
3
[Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Ned Tijdschr Geneeskd. 2001 Nov 24;145(47):2294-5.
4
Infliximab for rheumatoid arthritis in a patient with tuberculosis.
N Engl J Med. 2006 Aug 17;355(7):740-1. doi: 10.1056/NEJMc053468.
5
Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
Rheumatology (Oxford). 2006 Mar;45(3):357-9. doi: 10.1093/rheumatology/kei264. Epub 2005 Dec 20.
6
Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
Rheumatology (Oxford). 2005 Jul;44(7):950-1. doi: 10.1093/rheumatology/keh635. Epub 2005 Apr 12.
7
Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Dermatol Online J. 2008 Sep 15;14(9):12.
8
[Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
Nihon Rinsho. 2013 Jul;71(7):1209-13.
9
Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition.
Chest. 2002 Sep;122(3):1093-6. doi: 10.1378/chest.122.3.1093.
10
Infliximab treatment of rheumatoid arthritis.
Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii. doi: 10.1016/j.rdc.2004.01.009.
引用本文的文献
1
Adverse effects of biologic anti-inflammatory agents on the respiratory system: A review.
Afr J Thorac Crit Care Med. 2021 Jun 23;27(2). doi: 10.7196/AJTCCM.2021.v27i2.117. eCollection 2021.
Zotero 插件